World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
27531
World Ranking
11664
National Ranking
5019

Faramarz Ismail-Beigi publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Faramarz Ismail-Beigi sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 201 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Faramarz Ismail-Beigi D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Faramarz Ismail-Beigi sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Faramarz Ismail-Beigi is affiliated with Case Western Reserve University in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with significant contributions focusing on Endocrinology, Diabetes and Metabolism. Their academic work also intersects with Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, and Genetics as key subfields.

Their scholarly output encompasses topics that include diabetes treatment and management, metabolism related to diabetes and cancer, pancreatic function and diabetes, as well as diabetes management and research. Further areas of interest cover diabetes and associated disorders, liver disease diagnosis and treatment, and cardiovascular risks tied to diabetes and lipoproteins.

Frequent co-authors collaborating with Faramarz Ismail-Beigi include:

  • Michael A. Weiss
  • Mohammad E. Khamseh
  • Naji Younes
  • Ashok Balasubramanyam
  • Margaret Tiktin

Their work has been published extensively in various scholarly venues, notably:

  • UNC Libraries
  • Diabetes Care
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Diabetes
  • Advances in Therapy

Representative recent publications by Faramarz Ismail-Beigi include:

  • "Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes" (2020), Journal of Diabetes
  • "Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial" (2020), Advances in Therapy
  • "Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial" (2021), Diabetes Therapy
  • "Glucocorticoid-Induced Fatty Liver Disease" (2020), Diabetes Metabolic Syndrome and Obesity
  • "Intermittent fasting and 'metabolic switch': Effects on metabolic syndrome, prediabetes and type 2 diabetes" (2020), Diabetes Obesity and Metabolism

Best Publications

  • Effects of intensive glucose lowering in type 2 diabetes

    Hertzel C Gerstein;Michael E Miller;Robert P Byington

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

    Faramarz Ismail-Beigi;Timothy Craven;Mary Ann Banerji;Jan Basile

  • Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

    Hertzel C. Gerstein;Michael E. Miller;Saul Genuth;Faramarz Ismail-Beigi

  • Regulation of glut1 mRNA by Hypoxia-inducible Factor-1 INTERACTION BETWEEN H-ras AND HYPOXIA

    Changhu Chen;Nabendu Pore;Alireza Behrooz;Faramarz Ismail-Beigi

  • Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials

    Faramarz Ismail-Beigi;Etie Moghissi;Margaret Tiktin;Irl B. Hirsch

  • DECREASED ABSORPTION OF CALCIUM, MAGNESIUM, ZINC AND PHOSPHORUS BY HUMANS DUE TO INCREASED FIBER AND PHOSPHORUS CONSUMPTION AS WHEAT BREAD

    John G. Reinhold;Bahram Faradji;Parichehr Abadi;Faramarz Ismail-Beigi

  • Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis

    Steven G. Coca;Faramarz Ismail-Beigi;Nowreen Haq;Harlan M. Krumholz

  • Mechanism of thyroid calorigenesis: role of active sodium transport.

    Faramarz Ismail-Beigi;Isidore S. Edelman

  • Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

    Hertzel C Gerstein;Matthew C Riddle;David M Kendall;Robert M Cohen

  • Regulation of glucose transport by hypoxia.

    Jin-Zhong Zhang;Alireza Behrooz;Faramarz Ismail-Beigi

  • Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.

    Alireza Behrooz;Faramarz Ismail-Beigi

  • Glycemic Management of Type 2 Diabetes Mellitus

    Faramarz Ismail-Beigi

  • Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport.

    Wafa Abbud;Sue Habinowski;Jin Zhong Zhang;Julie Kendrew

  • A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea.

    Tanya G Weinstock;Xuelei Wang;Michael Rueschman;Faramarz Ismail-Beigi

  • Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.

    Hertzel C Gerstein;Michael E Miller;Faramarz Ismail-Beigi;Joe Largay

  • Protective hinge in insulin opens to enable its receptor engagement.

    John G. Menting;Yanwu Yang;Shu Jin Chan;Nelson B. Phillips

  • Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes.

    Marshall B. Elam;Henry N. Ginsberg;Laura C. Lovato;Marshall Corson

  • Overexpression of stomatin depresses GLUT-1 glucose transporter activity

    Jin Zhong Zhang;Wafa Abbud;Rainer Prohaska;Faramarz Ismail-Beigi

  • Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.

    Aman Rajpal;Leili Rahimi;Faramarz Ismail-Beigi;Faramarz Ismail-Beigi

Frequent Co-Authors

Michael A. Weiss
Michael A. Weiss Case Western Reserve University
Hertzel C. Gerstein
Hertzel C. Gerstein McMaster University
Michael C. Lawrence
Michael C. Lawrence Walter and Eliza Hall Institute of Medical Research
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Robert M. Cohen
Robert M. Cohen University of Cincinnati Medical Center
Silvio E. Inzucchi
Silvio E. Inzucchi Yale University
Patrick J. O'Connor
Patrick J. O'Connor HealthPartners
William C. Cushman
William C. Cushman University of Tennessee Health Science Center
Richard H. Grimm
Richard H. Grimm University of Minnesota
Steven E. Kahn
Steven E. Kahn University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry can open the door to varied healthcare careers, including roles in health information management and medical coding. Many students consider an him degree to expand their career options. This qualification prepares you for the growing demand in managing medical records, data, and information systems in healthcare settings.

Medical coding is another popular field, offering flexibility and competitive salaries. If you’re curious about earning potential, learn more about medical.coder salary and how this role can align with your science background.

It’s also worth understanding cpc vs ccs certifications, both key credentials for medical coding professionals. Each has different requirements and career impacts.

Considering the job market? Read about is medical billing and coding in demand to help gauge the career outlook. With the right online degree and certification, these growing healthcare pathways may be an excellent fit for Biology and Biochemistry graduates.

Best Scientists Citing Faramarz Ismail-Beigi

Trending Scientists

Recently Published Articles